Characterizing phenotypes and outcomes of drug‐associated liver injury using electronic medical record data

Abstract

Study results align with earlier prospective studies, supporting the value of standardized methodology to identify drug-associated liver injury in the EMR. These methods can potentially enhance safety and clinical outcomes.